UnitedHealth Group (NYSE:UNH) remains under pressure in recent trading and is down about 36% over the past year. Despite the ...

UnitedHealth Group (UNH) is back in the spotlight after fresh U.S. healthcare reform proposals targeting insurance brokers, ...

Optum notable drugs nearing FDA approval include Anaphylm, Sotyktu, and insulin icodec with decisions expected early 2026.

Detailed price information for Unitedhealth Group Inc (UNH-N) from The Globe and Mail including charting and trades.

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $260.0 to $450.0 for UnitedHealth Group over the last 3 months.

Nonetheless, its LTM Revenue Growth of 10% is lower than Centene’s 15%, indicating a robust, mature foundation with ...

Optum Ventures backs oncology AI startup Risa Labs in an $11.1M series A to accelerate AI platform deployment in U.S. cancer care settings.

All of this means that, right now in January, for investors who can accept the uncertainties I mentioned above, UnitedHealth ...

AI startup RISA Labs raises $11.1M Series A to scale its AI operating system for oncology, cutting authorization delays, ...

Pharmacy deserts are spreading across America. In one rural Arizona town, the only independent pharmacy is doing everything ...

A new AI tool is being tested in Oklahoma to process prior authorizations in Medicare. These Oklahomans say they're worried.

A group of nearly 20 pharmacy companies have been named in a lawsuit filed by Missouri's attorney general for alleged insulin price manipulation and fraud. Missouri AG Catherine Hanaway announced her ...